The role of (pro)renin receptor and its soluble form in cardiovascular diseases

The renin-angiotensin system (RAS) is a major classic therapeutic target for cardiovascular diseases. In addition to the circulating RAS, local tissue RAS has been identified in various tissues and plays roles in tissue inflammation and tissue fibrosis. (Pro)renin receptor (PRR) was identified as a...

Full description

Bibliographic Details
Main Authors: Boyang Wang, Haipeng Jie, Shuangxi Wang, Bo Dong, Yunzeng Zou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1086603/full
_version_ 1811170226764513280
author Boyang Wang
Boyang Wang
Boyang Wang
Haipeng Jie
Haipeng Jie
Shuangxi Wang
Bo Dong
Bo Dong
Bo Dong
Yunzeng Zou
author_facet Boyang Wang
Boyang Wang
Boyang Wang
Haipeng Jie
Haipeng Jie
Shuangxi Wang
Bo Dong
Bo Dong
Bo Dong
Yunzeng Zou
author_sort Boyang Wang
collection DOAJ
description The renin-angiotensin system (RAS) is a major classic therapeutic target for cardiovascular diseases. In addition to the circulating RAS, local tissue RAS has been identified in various tissues and plays roles in tissue inflammation and tissue fibrosis. (Pro)renin receptor (PRR) was identified as a new member of RAS in 2002. Studies have demonstrated the effects of PRR and its soluble form in local tissue RAS. Moreover, as an important part of vacuolar H+-ATPase, it also contributes to normal lysosome function and cell survival. Evidently, PRR participates in the pathogenesis of cardiovascular diseases and may be a potential therapeutic target of cardiovascular diseases. This review focuses on the effects of PRR and its soluble form on the physiological state, hypertension, myocardial ischemia reperfusion injury, heart failure, metabolic cardiomyopathy, and atherosclerosis. We aimed to investigate the possibilities and challenges of PRR and its soluble form as a new therapeutic target in cardiovascular diseases.
first_indexed 2024-04-10T16:53:31Z
format Article
id doaj.art-d53875ac33f64387a040ffa89fd19898
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-10T16:53:31Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-d53875ac33f64387a040ffa89fd198982023-02-07T10:17:32ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-02-011010.3389/fcvm.2023.10866031086603The role of (pro)renin receptor and its soluble form in cardiovascular diseasesBoyang Wang0Boyang Wang1Boyang Wang2Haipeng Jie3Haipeng Jie4Shuangxi Wang5Bo Dong6Bo Dong7Bo Dong8Yunzeng Zou9Department of Cardiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaDepartment of Cardiology, Shandong University of Traditional Chinese Medicine, Jinan, ChinaDepartment of Cardiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaKey Laboratory of Cardiovascular Remodeling and Function Research, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Cardiology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaDepartment of Cardiology, Shandong University of Traditional Chinese Medicine, Jinan, ChinaShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaThe renin-angiotensin system (RAS) is a major classic therapeutic target for cardiovascular diseases. In addition to the circulating RAS, local tissue RAS has been identified in various tissues and plays roles in tissue inflammation and tissue fibrosis. (Pro)renin receptor (PRR) was identified as a new member of RAS in 2002. Studies have demonstrated the effects of PRR and its soluble form in local tissue RAS. Moreover, as an important part of vacuolar H+-ATPase, it also contributes to normal lysosome function and cell survival. Evidently, PRR participates in the pathogenesis of cardiovascular diseases and may be a potential therapeutic target of cardiovascular diseases. This review focuses on the effects of PRR and its soluble form on the physiological state, hypertension, myocardial ischemia reperfusion injury, heart failure, metabolic cardiomyopathy, and atherosclerosis. We aimed to investigate the possibilities and challenges of PRR and its soluble form as a new therapeutic target in cardiovascular diseases.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1086603/fullhypertensionfibrosiscardiovascular diseaserenin-angiotensin system(pro)renin receptor
spellingShingle Boyang Wang
Boyang Wang
Boyang Wang
Haipeng Jie
Haipeng Jie
Shuangxi Wang
Bo Dong
Bo Dong
Bo Dong
Yunzeng Zou
The role of (pro)renin receptor and its soluble form in cardiovascular diseases
Frontiers in Cardiovascular Medicine
hypertension
fibrosis
cardiovascular disease
renin-angiotensin system
(pro)renin receptor
title The role of (pro)renin receptor and its soluble form in cardiovascular diseases
title_full The role of (pro)renin receptor and its soluble form in cardiovascular diseases
title_fullStr The role of (pro)renin receptor and its soluble form in cardiovascular diseases
title_full_unstemmed The role of (pro)renin receptor and its soluble form in cardiovascular diseases
title_short The role of (pro)renin receptor and its soluble form in cardiovascular diseases
title_sort role of pro renin receptor and its soluble form in cardiovascular diseases
topic hypertension
fibrosis
cardiovascular disease
renin-angiotensin system
(pro)renin receptor
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1086603/full
work_keys_str_mv AT boyangwang theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT boyangwang theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT boyangwang theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT haipengjie theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT haipengjie theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT shuangxiwang theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT bodong theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT bodong theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT bodong theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT yunzengzou theroleofproreninreceptoranditssolubleformincardiovasculardiseases
AT boyangwang roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT boyangwang roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT boyangwang roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT haipengjie roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT haipengjie roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT shuangxiwang roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT bodong roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT bodong roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT bodong roleofproreninreceptoranditssolubleformincardiovasculardiseases
AT yunzengzou roleofproreninreceptoranditssolubleformincardiovasculardiseases